M, N., CT, S., AP, J., Z, X., SR, V., RE, S., . . . I, R. (2025). Assessment of anti-CD69 antibody therapy alone or in combination with anti-PD-1 in murine GBM. Expert review of clinical immunology, 21(2), 239. https://doi.org/10.1080/1744666X.2024.2412770
Chicago Style (17th ed.) CitationM, Nisnboym, et al. "Assessment of Anti-CD69 Antibody Therapy Alone or in Combination with Anti-PD-1 in Murine GBM." Expert Review of Clinical Immunology 21, no. 2 (2025): 239. https://doi.org/10.1080/1744666X.2024.2412770.
MLA (9th ed.) CitationM, Nisnboym, et al. "Assessment of Anti-CD69 Antibody Therapy Alone or in Combination with Anti-PD-1 in Murine GBM." Expert Review of Clinical Immunology, vol. 21, no. 2, 2025, p. 239, https://doi.org/10.1080/1744666X.2024.2412770.